Search research articles
Contact Us
Filters
Showing results (771-780 of 962) with videos related to
Page
of 97
Sort By:
Circulation. Cardiovascular Interventions
|
September 17, 2017
White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry)
Binita Shah, Usman Baber, Stuart J Pocock, et al.
American Heart Journal
|
March 1, 2014
Design and rationale of the TOTAL trial: a randomized trial of routine aspiration ThrOmbecTomy with percutaneous coronary intervention (PCI) versus PCI ALone in patients with ST-elevation myocardial infarction undergoing primary PCI
Sanjit S Jolly, John Cairns, Salim Yusuf, et al.
European Journal of Preventive Cardiology
|
September 22, 2025
Benefit of Icosapent Ethyl Across Types and Sizes of Myocardial Infarction in REDUCE-IT
Chen Gurevitz, Deepak L Bhatt, Robert P Giugliano, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
September 22, 2016
Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry
Jaya Chandrasekhar, Sameer Bansilal, Usman Baber, et al.
Circulation
|
October 28, 2021
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG
Subodh Verma, Deepak L Bhatt, Ph Gabriel Steg, et al.
The Canadian Journal of Cardiology
|
April 28, 2023
Lipoprotein(a) and the Effect of Alirocumab on Revascularization After Acute Coronary Syndrome
P Gabriel Steg, Michael Szarek, Marco Valgimigli, et al.
Circulation
|
July 22, 2024
Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome
Marco Valgimigli, Antonio Landi, Dominick J Angiolillo, et al.
Nature Reviews. Cardiology
|
March 31, 2025
Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism
Davide Capodanno, John H Alexander, M Cecilia Bahit, et al.
Journal of the American College of Cardiology
|
August 12, 2017
Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease
Daniel Lindholm, Johan Lindbäck, Paul W Armstrong, et al.
JAMA Cardiology
|
June 24, 2026
Dual Antiplatelet Therapy Duration in Patients at High Bleeding Risk: A Systematic Review and Meta-Analysis
Andrea Zito, Antonio Landi, Deepak L Bhatt, et al.
Page
of 97
Search research articles
Search
Showing results (771-780 of 962) with videos related to
Sort By:
Page
of 97
Circulation. Cardiovascular Interventions
|
September 17, 2017
White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry)
Binita Shah, Usman Baber, Stuart J Pocock, et al.
American Heart Journal
|
March 1, 2014
Design and rationale of the TOTAL trial: a randomized trial of routine aspiration ThrOmbecTomy with percutaneous coronary intervention (PCI) versus PCI ALone in patients with ST-elevation myocardial infarction undergoing primary PCI
Sanjit S Jolly, John Cairns, Salim Yusuf, et al.
European Journal of Preventive Cardiology
|
September 22, 2025
Benefit of Icosapent Ethyl Across Types and Sizes of Myocardial Infarction in REDUCE-IT
Chen Gurevitz, Deepak L Bhatt, Robert P Giugliano, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
September 22, 2016
Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry
Jaya Chandrasekhar, Sameer Bansilal, Usman Baber, et al.
Circulation
|
October 28, 2021
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG
Subodh Verma, Deepak L Bhatt, Ph Gabriel Steg, et al.
The Canadian Journal of Cardiology
|
April 28, 2023
Lipoprotein(a) and the Effect of Alirocumab on Revascularization After Acute Coronary Syndrome
P Gabriel Steg, Michael Szarek, Marco Valgimigli, et al.
Circulation
|
July 22, 2024
Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome
Marco Valgimigli, Antonio Landi, Dominick J Angiolillo, et al.
Nature Reviews. Cardiology
|
March 31, 2025
Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism
Davide Capodanno, John H Alexander, M Cecilia Bahit, et al.
Journal of the American College of Cardiology
|
August 12, 2017
Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease
Daniel Lindholm, Johan Lindbäck, Paul W Armstrong, et al.
JAMA Cardiology
|
June 24, 2026
Dual Antiplatelet Therapy Duration in Patients at High Bleeding Risk: A Systematic Review and Meta-Analysis
Andrea Zito, Antonio Landi, Deepak L Bhatt, et al.
Page
of 97